BOZEMAN, MT, July 16, 2011
/24-7PressRelease/ -- BioScience Laboratories announces the capability of product efficacy testing versus Clostridium difficile spores. In response to the recent hospital infection related fatalities caused by Clostridium difficile, BioScience Laboratories reminds disinfectant manufacturers that efficacy versus Clostridium difficile spores can be determined through in-vitro testing. In spore form, Clostridium difficile can survive heat and drying, and is resistant to many legacy disinfectants. These spores can live up to five months on surfaces and in the environment. Efficacy testing performed at BioScience Laboratories can show that new disinfectant product formulations are effective versus Clostridium difficile spores.
For additional information, contact:
John Dyba
BioScience Laboratories, Inc.
1-877-858-2754
FAX 406-586-7930
jdyba@biosciencelabs.com
www.biosciencelabs.comNow in its 20th year, BioScience Laboratories, Inc. provides antimicrobial product testing and result interpretation grounded in science. BioScience Laboratories, Inc. strives to assist its clients in strengthening their current market positions through product testing and aid in the development of new products and meeting federal regulatory agency requirements for the healthcare, pharmaceutical, personal care, and consumer products markets.
---
Press release service and press release distribution provided by http://www.24-7pressrelease.com# # #
Press Release Keywords:Read more Press Releases from John Dyba:
